Increase of sclerostin in blood and bone from CKD-2 to CKD-5D is 3.5- and 4.9-fold and appears more parallel confirming the prevailing knowledge that sclerostin is expressed almost exclusively in bone [31]. Here, SOST is linked to chronic kidney disease.